Mill Capital Management’s Novartis NVS Stock Holding History

Mill Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$670K	Hold	4,388	–	–	0.05%	88
2025 Q4	$605K	Hold	4,388	–	–	0.04%	91
2025 Q3	$563K	Sell	4,388 -50	-1%	-$6.1K	0.04%	92
2025 Q2	$537K	Hold	4,438	–	–	0.04%	89
2025 Q1	$495K	Sell	4,438 -413	-9%	-$44K	0.04%	92
2024 Q4	$472K	Sell	4,851 -2,483	-34%	-$265K	0.04%	90
2024 Q3	$844K	Hold	7,334	–	–	0.07%	82
2024 Q2	$781K	Sell	7,334 -750	-9%	-$75.3K	0.06%	81
2024 Q1	$782K	Sell	8,084 -300	-4%	-$30.8K	0.07%	86
2023 Q4	$847K	Hold	8,384	–	–	0.08%	83
2023 Q3	$854K	Sell	8,384 -175	-2%	-$17.8K	0.08%	80
2023 Q2	$864K	Hold	8,559	–	–	0.08%	82
2023 Q1	$787K	Sell	8,559 -300	-3%	-$26.2K	0.08%	85
2022 Q4	$804K	Hold	8,859	–	–	0.09%	80
2022 Q3	$673K	Buy	8,859 +1,013	+13%	+$84K	0.08%	82
2022 Q2	$663K	Hold	7,846	–	–	0.07%	83
2022 Q1	$688K	Sell	7,846 -400	-5%	-$34.6K	0.07%	90
2021 Q4	$721K	Buy	+8,246	New	+$685K	0.07%	75

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mill Capital Management's NVS Position: Q1 2026 in Review

Mill Capital Management held its Novartis (NVS) position steady in Q1 2026 at 4,388 shares worth $670K. The position accounts for 0.05% of the portfolio, ranked #88.

Mill Capital Management first reported a position in NVS in Q4 2021 and has held it in 18 quarters since. The position peaked at $864K in Q2 2023. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Mill Capital Management held 4,388 shares of Novartis worth $670K as of Q1 2026.
Mill Capital Management left its Novartis share count unchanged in Q1 2026.
Novartis made up 0.05% of Mill Capital Management's portfolio in Q1 2026, its #88 holding.
Mill Capital Management first reported a position in Novartis in Q4 2021 and has held it in 18 quarters since.
Mill Capital Management's Novartis position peaked at $864K in Q2 2023.
1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Mill Capital Management's 13F filing for Q1 2026, filed 4 May 2026.